Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/89
Title: Bilateral papilledema on sunitnib therapy for advanced renal cell carcinoma.
Authors: Yoong, Jaclyn
Chong, Geoff
Hamilton, Kate
Issue Date: 2011
Publisher: Humana Press Inc.
Place of publication: Totowa, N.J.
Journal title: Medical Oncology
Volume: 28
Issue: 1
Start Page: S395
End Page: S397
Abstract: We report the case of a 59-year-old man with advanced renal cell carcinoma who developed bilateral papilledema while on therapy with sunitinib, a multi-targeted tyrosine kinase inhibitor (TKI). While papilledema has been reported in association with another TKI (imatinib), the association between sunitinib and papilledema has not previously been reported in the literature.
URI: http://hdl.handle.net/11054/89
metadata.dc.relation.uri: http://rd.springer.com/article/10.1007%2Fs12032-010-9719-5?LI=true#
ISSN: 1357-0560
Internal ID Number: 00075
Health Subject: CASE REPORTS
CARCINOMA - RENAL CELL - DIAGNOSIS
CARCINOMA - RENAL CELL - DRUG THERAPY
HUMANS
INDOLES - ADVERSE EFFECTS
INDOLES - THERAPEUTIC USE
KIDNEY NEOPLASMS - DIAGNOSIS
KIDNEY NEOPLASMS - DRUG THERAPY
MALE
MIDDLE AGED
PAPILLEDEMA - CHEMICALLY INDUCED
PAPILLEDEMA - DIAGNOSIS
PYRROLES - ADVERSE EFFECTS
PYRROLES - THERAPEUTIC USE
INDOLES
PYRROLES
SUNITINIB
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.